Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial

Paz-Ares L.Kim T.M.Vicente D.Felip E.Lee D.H.Lee K.H.CHIA-CHI LINFlor M.J.Di Nicola M.Alvarez R.M.Dussault I.Helwig C.Ojalvo L.S.Gulley J.L.Cho B.C.2022-09-152022-09-1520201556-0864https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084225972&doi=10.1016%2fj.jtho.2020.03.003&partnerID=40&md5=5ab10a1e528d29f3e950ede1e653a819https://scholars.lib.ntu.edu.tw/handle/123456789/620233[SDGs]SDG3Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trialjournal article10.1016/j.jtho.2020.03.003321734642-s2.0-85084225972